Latest News for: cd8

Edit

Mozart Therapeutics Completes Ph1a Study in Healthy Adults; Data Shows MTX-101 is Well Tolerated and Selectively Activates CD8 Treg

PR Newswire 17 Mar 2025
... T cells, and that engagement with MTX-101 results in CD8 Treg activation ... MTX-101 is an antigen-agnostic bispecific antibody targeting inhibitory KIR and CD8 expressed on regulatory CD8 T cells.
  • 1
×